Discover SM Podcast Podcast Por Blueprint Medicines arte de portada

Discover SM Podcast

Discover SM Podcast

De: Blueprint Medicines
Escúchala gratis

Welcome to the Discover SM Podcast, a podcast series exploring the world of systemic mastocytosis (SM). Initiated, organised and funded by Blueprint Medicines, a Sanofi company, this series is intended for international healthcare professionals (HCPs) outside the United States and the United Kingdom.

This podcast provides expert insights and practical guidance – from improving recognition of early signs to navigating diagnostic pathways. Whether you’re looking to deepen your understanding of this rare, heterogeneous condition or learn about diagnostic hallmarks, this series offers accessible and engaging content tailored for HCPs. Tune in to stay informed and spot missing “puzzle pieces” in complex cases, helping to shorten the diagnostic journey.

To learn more about SM, visit our Discover SM website for a wealth of information and resources, from webinar videos to downloadable guides such as a symptom checklist and algorithm leaflet.

INTBP-DAXSM-25.023, 12/2025

Copyright 2025 All rights reserved. Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Solving the SM Puzzle: From symptoms to diagnosis

    Solving the SM Puzzle: From symptoms to diagnosis
    Mar 20 2026

    Episode 2 of DISCOVER SM – a podcast series developed for international HCPs to increase awareness of systemic mastocytosis (SM). This episode provides a practical overview of SM, discussing its common signs and symptoms, typical diagnostic pathways, and key diagnostic tests. Expert clinicians share their insights on recognising key findings and guiding the diagnostic process.

    For more information on SM, visit our Discover SM website.

    References: 1. Ungerstedt J, et al. Cancers (Basel). 2022;14(16):3942. 2. Schwaab J, et al. J Allergy Clin Immunol Pract. 2020;8(9):3121–3127.e1. 3. Valent P, et al. J Allergy Clin Immunol Pract. 2022;10(8):1999–2012.e6

    INTBP-DAXSM-25.022
    Más Menos
    20 m
  • Getting to know SM: From discovery to recognition

    Getting to know SM: From discovery to recognition
    Jan 12 2026

    Episode 1 of DISCOVER SM – a podcast series developed for international HCPs to increase awareness of systemic mastocytosis (SM). This episode provides an introduction to SM, exploring its origins, key features, and subtypes. Expert insights highlight how the understanding of SM has evolved over time, setting the foundation for recognising and diagnosing this rare disease.

    For more information on SM, visit our Discover SM website.

    References: 1. Gülen T, et al. J Intern Med. 2016;279(3):211–228. 2. Ungerstedt J, et al. Cancers (Basel). 2022;14(16):3942. 3. Valent P, et al. Cancer Res. 2017;77(6):1261–1270. 4. Rare Disease Advisor. Systemic Mastocytosis History. Available at: https://www.rarediseaseadvisor.com/hcp-resource/systemic-mastocytosis-history/. Last accessed October 2025. 5. Jensen RT. Hematol Oncol Clin North Am. 2000;14(3):579-623. 6. Theoharides TC, et al. N Engl J Med. 2015;373(2):163–172. 7. Gilreath JA, et al. Clin Pharmacol. 2019;11:77–92. 8. Pyatilova P, et al. World Allergy Organ J. 2023;16(11):100838. 9. Universitätsklinik für Innere Medizin I. Reference Centers. Available at:https://innere-med-1.meduniwien.ac.at/unsere-klinischen-abteilungen/haematologie-und-haemostaseologie/projekte/ecnm-registry-european-competence-network-mastocytosis/centers/reference-centers/. Last accessed October 2025. 10. Valent P, et al. J Allergy Clin Immunol Pract. 2022;10(8):1999–2012.e6. 11. Berezowska S, et al. Mod Pathol. 2014;27(1):19–29. 12. Valent P, et al. Hemasphere. 2021;5(11):e646. 13. Arber DA, et al. Blood. 2022;140(11):1200–1228. 14. Khoury JD, et al. Leukemia. 2022;36(7):1703–1719. 15. Pardanani A. Am J Hematol. 2023;98(7):1097–1116. 16. Veitch S, Radia DH. Diagnostics (Basel). 2023;14(1):80. 17. Levedahl KH, et al. Eur J Oncol Nurs. 2022:60:102172. 18. Triggiani M, et al. Clin Exp Allergy. 2025;55(9):784–794. 19. Jennings SV, et al. Immunol Allergy Clin North Am. 2018;38(3):505–525.

    INTBP-DAXSM-25.021, 10/2025
    Más Menos
    23 m
Todavía no hay opiniones